Advisory Services Network’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.56M | Sell |
12,181
-3,883
| -24% | -$485K | 0.02% | 745 |
|
|
2025
Q4 | $1.96M | Buy |
16,064
+5,351
| +50% | +$614K | 0.03% | 610 |
|
|
2025
Q3 | $1.07M | Buy |
10,713
+590
| +6% | +$53.1K | 0.02% | 832 |
|
|
2025
Q2 | $867K | Sell |
10,123
-1,463
| -13% | -$117K | 0.01% | 884 |
|
|
2025
Q1 | $940K | Sell |
11,586
-1,906
| -14% | -$170K | 0.02% | 788 |
|
|
2024
Q4 | $1.22M | Buy |
13,492
+3,588
| +36% | +$348K | 0.02% | 660 |
|
|
2024
Q3 | $918K | Hold |
9,904
| – | – | 0.02% | 748 |
|
|
2024
Q2 | $918K | Buy |
9,904
+1,555
| +19% | +$139K | 0.02% | 748 |
|
|
2024
Q1 | $792K | Sell |
8,349
-291
| -3% | -$27K | 0.02% | 777 |
|
|
2023
Q4 | $771K | Sell |
8,640
-4,049
| -32% | -$301K | 0.02% | 736 |
|
|
2023
Q3 | $927K | Sell |
12,689
-190
| -1% | -$15.2K | 0.02% | 662 |
|
|
2023
Q2 | $1.07M | Buy |
12,879
+168
| +1% | +$14.1K | 0.03% | 600 |
|
|
2023
Q1 | $969K | Buy |
12,711
+21
| +0.2% | +$1.74K | 0.03% | 622 |
|
|
2022
Q4 | $1.05M | Buy |
12,690
+36
| +0.3% | +$2.92K | 0.03% | 583 |
|
|
2022
Q3 | $1M | Buy |
12,654
+1,070
| +9% | +$90.2K | 0.04% | 546 |
|
|
2022
Q2 | $860K | Buy |
11,584
+3,321
| +40% | +$249K | 0.03% | 607 |
|
|
2022
Q1 | $743K | Buy |
8,263
+1,434
| +21% | +$132K | 0.02% | 732 |
|
|
2021
Q4 | $765K | Buy |
+6,829
| New | +$824K | 0.02% | 720 |
|
|
2021
Q3 | – | Sell |
-3,450
| Closed | -$467K | – | 3246 |
|
|
2021
Q2 | $467K | Buy |
+3,450
| New | +$454K | 0.01% | 906 |
|
|
2021
Q1 | – | Sell |
-592
| Closed | -$83K | – | 2967 |
|
|
2020
Q4 | $83K | Sell |
592
-8
| -1% | -$1.02K | ﹤0.01% | 1418 |
|
|
2020
Q3 | $67K | Buy |
+600
| New | +$67.3K | ﹤0.01% | 1445 |
|
|
2020
Q2 | – | Sell |
-1,321
| Closed | -$102K | – | 2758 |
|
|
2020
Q1 | $102K | Buy |
1,321
+376
| +40% | +$33.3K | 0.01% | 1070 |
|
|
2019
Q4 | $90K | Sell |
945
-284
| -23% | -$24.6K | ﹤0.01% | 1207 |
|
|
2019
Q3 | $108K | Hold |
1,229
| – | – | 0.01% | 1039 |
|
|
2019
Q2 | $108K | Buy |
1,229
+416
| +51% | +$35.5K | 0.01% | 1037 |
|
|
2019
Q1 | $74K | Sell |
813
-927
| -53% | -$78.9K | 0.01% | 1097 |
|
|
2018
Q4 | $125K | Buy |
1,740
+1,524
| +706% | +$123K | 0.01% | 828 |
|
|
2018
Q3 | $21K | Buy |
216
+2
| +0.9% | +$194 | ﹤0.01% | 1560 |
|
|
2018
Q2 | $21K | Buy |
214
+42
| +24% | +$3.86K | ﹤0.01% | 1538 |
|
|
2018
Q1 | $15K | Sell |
172
-169
| -50% | -$15.4K | ﹤0.01% | 1749 |
|
|
2017
Q4 | $29K | Sell |
341
-458
| -57% | -$38.4K | ﹤0.01% | 1493 |
|
|
2017
Q3 | $69K | Sell |
799
-97
| -11% | -$7.78K | 0.01% | 990 |
|
|
2017
Q2 | $69K | Buy |
896
+752
| +522% | +$53.3K | 0.01% | 954 |
|
|
2017
Q1 | $10K | Buy |
+144
| New | +$9.67K | ﹤0.01% | 1485 |
|
|
2016
Q3 | $4K | Hold |
60
| – | – | ﹤0.01% | 1624 |
|
|
2016
Q2 | $3K | Buy |
+60
| New | +$3.29K | ﹤0.01% | 1594 |
|
Other funds holding XBI
Advisory Services Network's XBI Position: Q1 2026 in Review
Advisory Services Network reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 24% in Q1 2026, selling an estimated $485K and leaving 12,181 shares worth $1.56M. The position accounts for 0.02% of the portfolio, ranked #745.
Advisory Services Network first reported a position in XBI in Q2 2016 and has held it in 36 quarters since. The position peaked at $1.96M in Q4 2025. 813 funds tracked by Wall St. Rank hold XBI as of Q1 2026.
- Advisory Services Network held 12,181 shares of State Street SPDR S&P Biotech ETF worth $1.56M as of Q1 2026.
- Advisory Services Network sold 3,883 State Street SPDR S&P Biotech ETF shares in Q1 2026, an estimated $485K.
- State Street SPDR S&P Biotech ETF made up 0.02% of Advisory Services Network's portfolio in Q1 2026, its #745 holding.
- Advisory Services Network first reported a position in State Street SPDR S&P Biotech ETF in Q2 2016 and has held it in 36 quarters since.
- Advisory Services Network's State Street SPDR S&P Biotech ETF position peaked at $1.96M in Q4 2025.
- 813 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.
Based on Advisory Services Network's 13F filing for Q1 2026, filed 15 May 2026.